Fortive (FTV) Stock Overview
Designs, develops, manufactures, and markets products, software, and services in the United States, China, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
FTV Community Fair Values
Create NarrativeSee what 10 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Fortive Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$55.09 |
| 52 Week High | US$64.56 |
| 52 Week Low | US$47.31 |
| Beta | 0.97 |
| 1 Month Change | -8.31% |
| 3 Month Change | -8.70% |
| 1 Year Change | 14.01% |
| 3 Year Change | -26.37% |
| 5 Year Change | -24.83% |
| Change since IPO | 13.35% |
Recent News & Updates
Recent updates
Seeking Alpha • Jul 23
Fortive's Continued Growth Does Not Justify An Upgrade At This Time
Summary Fortive Corporation remains rated 'Hold' due to fair absolute valuation despite consistent revenue and profitability growth. FTV's Intelligent Operating Solutions and Advanced Healthcare Solutions segments delivered robust organic growth, aided by pricing, volume, and productivity initiatives. Management guides for FY26 adjusted EPS of $2.90–$3.00, with adjusted operating cash flow projected to rise to $1.21 billion. Relative valuation is attractive versus peers, but not compelling enough on an absolute basis to warrant an upgrade without exceptional new data. Read the full article on Seeking Alpha
Narrative Update • Jul 03
FTV: Earnings Momentum And Buybacks Will Shape Future Return Profile
Analysts have raised the Fortive fair value estimate to about $64.36 from $62.19, reflecting a series of incremental price target increases on the stock. They point to supportive demand trends in areas such as power, data centers, aerospace and defense, and infrastructure.Analysis Article • Jun 21
Fortive (FTV) Stock Could Be 15.2% Below Fair Value as Digital Growth Narrative Builds
Why Fortive Stock Is On Investors’ Radar Fortive (FTV) shares have been getting more attention after a period of positive returns, with the stock up over the past month, past 3 months, and year to date. Investors are weighing how this recent performance lines up with the company’s fundamentals and valuation. See our latest analysis for Fortive. Over the past year Fortive’s share price has built steady momentum, with a 10.18% year to date share price return and a 16.71% total shareholder...
Narrative Update • Jun 19
FTV: Future P/E Compression Will Limit Support From Ongoing Buybacks
Fortive's analyst price target moves modestly higher in this update, supported by a slightly richer fair value estimate of $53.80 as analysts factor in recent target increases from several firms and modest adjustments to revenue growth, profit margin, and future P/E assumptions. Analyst Commentary on Fortive Stock Recent research on Fortive reflects a mix of optimism and restraint, with several firms adjusting price targets and ratings as they reassess revenue, margin, and P/E assumptions.
Narrative Update • Jun 04
FTV: Buybacks And Sequential Execution Will Support Future EPS Upside
Fortive's analyst price target is modestly higher, with recent Street research pointing to a series of $1 to $7 upward target revisions as analysts highlight sequential growth and adjust assumptions around revenue, margins, and future P/E multiples. Analyst Commentary Recent Street research on Fortive has leaned constructive, with several bullish analysts adjusting targets upward and one trimming a target by a small amount.Narrative Update • May 20
FTV: Buybacks And Sequential Execution Will Support Future Earnings Quality
Fortive's analyst price target has been raised by several firms in recent research, collectively edging higher by single digits in dollar terms. Analysts point to solid sequential growth and recent company execution to support slightly higher revenue growth and P/E expectations, even as profit margin assumptions are trimmed and the discount rate is nudged up.Narrative Update • May 02
FTV: Sterilization Demand And Buybacks Will Support Future Earnings Quality
Fortive's analyst fair value estimate has been nudged up by $1 to $73 after analysts weighed a mix of recent price target increases and trims alongside recalibrated assumptions for growth, margins and future P/E levels. Analyst Commentary Recent Street research on Fortive shows a mix of target price trims and increases, with bullish analysts generally leaning toward higher fair value assumptions even as some recalibrate their models.Narrative Update • Apr 16
FTV: Future P E Compression Will Challenge Buyback Support At Current Levels
Fortive's analyst price targets have seen a mixed reset, with one firm trimming its view by $7 while several others lifted their targets by $4 to $9, as analysts factor in modest tweaks to fair value, discount rate, revenue growth, profit margin, and future P/E assumptions. Analyst Commentary Recent research on Fortive shows a mix of optimism and caution, with several firms lifting their price targets and one trimming its view by $7.Narrative Update • Apr 02
FTV: Fair Value View Balances Buybacks Against Execution And P E Compression Risks
Analysts have nudged their fair value estimate for Fortive higher to $52.50 from $51.10, reflecting updated views on revenue growth, margins, and future P/E assumptions following a mix of recent price target hikes and one downgrade across the Street. Analyst Commentary Recent Street research on Fortive shows a mixed but generally cautious tone, with a cluster of price target increases alongside at least one downgrade and a later price target cut.Narrative Update • Mar 19
FTV: Fair Value Case Weighs Buybacks Against Execution And Multiple Compression Risks
Fortive's analyst price target has been adjusted slightly lower to $51.10. Analysts point to updated fair value estimates, refined discount rate assumptions, and refreshed views on revenue growth, margins, and future P/E multiples following a series of recent price target revisions across major firms.Narrative Update • Mar 05
FTV: North American Sterilization Demand Will Support Future Earnings Quality Upside
Analysts have lifted their price targets on Fortive, supporting a move in our fair value estimate from $66.00 to $72.00. They cited updated expectations for revenue growth, profitability and a lower forward P/E multiple.Narrative Update • Feb 19
FTV: Recent Rating Shift And Buybacks Will Shape Future Return Profile
Our updated Fortive narrative reflects a higher implied price target of about $62, as analysts factor in steadier revenue growth assumptions, slightly stronger profit margins, a modestly lower discount rate, and a similar forward P/E, consistent with a series of recent price target increases across the Street. Analyst Commentary Recent Street research shows a cluster of higher Fortive price targets, alongside at least one downgrade.Narrative Update • Feb 04
FTV: JPMorgan Downgrade And Buybacks Will Shape A Measured Return Profile
Analysts have trimmed their price target on Fortive to US$58.13, citing a slightly lower discount rate, modestly softer revenue expectations and a higher assumed profit margin supported by a reduced future P/E multiple. Analyst Commentary Recent commentary around the new US$58.13 price target reflects a mixed view on Fortive, with the latest JPMorgan downgrade underlining both execution opportunities and areas of concern for valuation and growth.Narrative Update • Jan 21
FTV: Balanced Outlook As Healthcare Demand And Buybacks Shape Future Returns
Narrative Update The analyst price target for Fortive has shifted from approximately $56.13 to $58.13, as analysts cite recent model updates and sequential improvements in North American demand for sterilization and biomedical equipment, along with higher AHS adjusted EBITDA driven by gross profit growth and lower costs. Analyst Commentary Recent research on Fortive reflects a mix of optimism on execution and caution around upside potential, which is showing up in both price target changes and rating shifts.Narrative Update • Jan 06
FTV: Fair Value View Balances Higher Demand With Margin Execution Risks
Analysts have increased their fair value estimate for Fortive from US$50.00 to US$52.00, citing refreshed models after the Q3 report and Street research that points to improved North American demand for sterilization and biomedical equipment, stronger AHS adjusted EBITDA margins, and updated price targets clustered around US$55 to US$58. Analyst Commentary Recent Street research on Fortive points to updated price targets clustered in the US$55 to US$58 range, with analysts revising their models following the Q3 report.Analysis Article • Dec 27
Estimating The Fair Value Of Fortive Corporation (NYSE:FTV)
Key Insights The projected fair value for Fortive is US$53.12 based on 2 Stage Free Cash Flow to Equity Current share...Narrative Update • Dec 15
FTV: North American Sterilization Demand Will Support Earnings Quality And Upside Potential
Analysts have modestly raised their blended price target on Fortive to about $58 per share from roughly $55, citing improved North American demand for sterilization and biomedical equipment, stronger margins in Advanced Healthcare Solutions, and updated post earnings financial models that still reflect slightly softer long term growth and profitability assumptions. Analyst Commentary Bullish analysts are pointing to a constructive risk reward profile for Fortive, highlighting that incremental execution gains and healthier end market trends can support the recent step up in valuation.Narrative Update • Oct 20
Recurring Software Trends Will Secure Resilience Amid Tariff Uncertainty
Analysts have lowered their fair value estimate for Fortive to $56.13 from $57.25. They cite a tougher outlook and more challenging revenue growth projections for the remainder of the year.Narrative Update • Sep 18
Recurring Software Trends Will Secure Resilience Amid Tariff Uncertainty
Analysts have lowered Fortive's price target to $57.25 due to skepticism over the company's ability to meet guidance amid slowing growth in its strongest segment, caution around macro headwinds post-Ralliant spinoff, and minimal near-term revenue growth. Analyst Commentary Persistent skepticism regarding Fortive's ability to achieve its full-year guidance following a cautious update and lack of supportive industry data.Narrative Update • Sep 03
Recurring Software Trends Will Secure Resilience Amid Tariff Uncertainty
Analysts have lowered Fortive’s target price to $60.50, citing uncertainty about achieving updated guidance following the Ralliant spin-off, ongoing topline and margin pressures, and diminished visibility post-restructuring. Analyst Commentary Bullish analysts highlight Fortive's high earnings visibility and strong recurring revenue profile (~50%+), expecting portfolio reviews and strategic focus on workflow management software and healthcare to support margin resilience.Seeking Alpha • Mar 10
Fortive Seeing Signs Of Improvement, But Valuation Doesn't Make It An Easy Call
Summary Fortive's fourth-quarter results (and full 2024 results) showed fairly ordinary performance, with revenue and margins missing targets, and the business model didn't meaningfully outperform peers through the cycle. 2025 should be a better year, and I'd expect Fortive's businesses to recover ahead of more manufacturing and machinery-focused peers. The upcoming split of Precision Technologies into Ralliant may reduce complexity but is unlikely to significantly add or destroy value, but I can see potential strategic bidders for Tektronix. Despite cautious optimism for 2025, FTV's valuation doesn't justify a premium, given its inability to outgrow inflation and deliver superior full-cycle performance. Read the full article on Seeking AlphaShareholder Returns
| FTV | US Machinery | US Market | |
|---|---|---|---|
| 7D | -0.2% | -0.7% | -0.1% |
| 1Y | 14.0% | 24.9% | 11.9% |
Return vs Industry: FTV underperformed the US Machinery industry which returned 24.9% over the past year.
Return vs Market: FTV exceeded the US Market which returned 11.9% over the past year.
Price Volatility
| FTV volatility | |
|---|---|
| FTV Average Weekly Movement | 3.7% |
| Machinery Industry Average Movement | 5.7% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in US Market | 15.1% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: FTV has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: FTV's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | 10,000 | Olumide Soroye | www.fortive.com |
Fortive Corporation designs, develops, manufactures, and markets products, software, and services in the United States, China, and internationally. It operates through Intelligent Operating Solutions and Advanced Healthcare Solutions segments. The Intelligent Operating Solutions segment provides advanced instrumentation, software, and services, including maintenance, repair, measurement and condition monitoring, facility and asset lifecycle software applications, and connected worker safety and compliance solutions for manufacturing, process industries, healthcare, utilities and power, communications and electronics, and other industries.
Fortive Corporation Fundamentals Summary
| FTV fundamental statistics | |
|---|---|
| Market cap | US$16.61b |
| Earnings (TTM) | US$602.20m |
| Revenue (TTM) | US$4.32b |
27.6x
P/E Ratio3.9x
P/S RatioIs FTV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| FTV income statement (TTM) | |
|---|---|
| Revenue | US$4.32b |
| Cost of Revenue | US$1.59b |
| Gross Profit | US$2.73b |
| Other Expenses | US$2.13b |
| Earnings | US$602.20m |
Last Reported Earnings
Jul 03, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.99 |
| Gross Margin | 63.23% |
| Net Profit Margin | 13.95% |
| Debt/Equity Ratio | 57.8% |
How did FTV perform over the long term?
See historical performance and comparisonDividends
0.4%
Current Dividend Yield6%
Payout RatioDoes FTV pay a reliable dividends?
See FTV dividend history and benchmarks| Fortive dividend dates | |
|---|---|
| Ex Dividend Date | Sep 04 2026 |
| Dividend Pay Date | Sep 25 2026 |
| Days until Ex dividend | 18 days |
| Days until Dividend pay date | 3 days |
Does FTV pay a reliable dividends?
See FTV dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/09/21 21:35 |
| End of Day Share Price | 2026/09/21 00:00 |
| Earnings | 2026/07/03 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Fortive Corporation is covered by 29 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| John Eade | Argus Research Company |
| Robert Mason | Baird |
| Quinn Fredrickson | Baird |